Concepedia

High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin

Óscar Arrieta, Luis A. Medina, Enrique Estrada-Lobato, Víctor-Osvaldo Mendoza-García

Cancer Chemotherapy and Pharmacology · 2014 · 50 citations · 17 references

DOI

Concepts

References

17

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

, , +13

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Jan P. van Meerbeeck, Rabab Gaafar, Christian Manegold et al. · Journal of Clinical Oncology · 2005 · 621 citations · Full text

, , +14

Metabolic Imaging of Malignant Pleural Mesothelioma With Fluorodeoxyglucose Positron Emission Tomography

François Bénard, Daniel H. Sterman, Robin J. Smith et al. · CHEST Journal · 1998 · 257 citations · Full text

, , +17

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

Silvia Novello, Carmine Pinto, Valter Torri et al. · Critical Reviews in Oncology/Hematology · 2016 · 111 citations · Full text

, , +14

Mesothelioma mortality in Great Britain from 1968 to 2001

Damien McElvenny, Andrew Darnton, Malcolm J Price et al. · Occupational Medicine · 2005 · 104 citations · Full text

, , +16